Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Boldo (Peumus boldus) is a South American medicinal plant containing boldine alkaloids and phenolic compounds like gallic acid that demonstrate antioxidant and antimicrobial activities. The plant's essential oils and alkaloids show promise for digestive and liver support, though human clinical evidence remains limited.
Origin & History
Peumus boldus (Boldo) is an evergreen shrub native to central Chile and parts of Brazil, Argentina, Peru, and the Mediterranean region, belonging to the Monimiaceae family. The leaves and bark are harvested and processed through alcohol extraction for boldine isolation or steam distillation for essential oils. The leaves contain 2-4% volatile oil and are rich in alkaloids, particularly boldine.
Research Narrative (Provisional)
The research dossier reveals a complete absence of human clinical trials, RCTs, or meta-analyses for Peumus boldus. All reported pharmacological activities including antioxidant, antimicrobial, antifungal, and anti-parasitic effects are derived exclusively from in vitro and animal studies. No PubMed PMIDs for human studies were identified in the available research.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Peumus boldus (Boldo) leaf is primarily valued for its bioactive phytochemical content rather than macronutrient density. Macronutrients: Protein content is minimal (estimated 5-8% dry weight basis, typical of dried aromatic leaves); carbohydrates including structural polysaccharides and tannins contribute to bulk composition; fat content is low (<3% dry weight), with essential oil fraction representing approximately 1-3% of fresh leaf weight. Micronutrients: Contains modest levels of potassium, calcium, and magnesium consistent with dried leaf material; specific mineral concentrations are not well-characterized in standardized analytical literature. Bioactive compounds (primary interest): Alkaloids total approximately 0.25-0.5% dry weight, dominated by boldine (the principal alkaloid, ~25-30 mg/g dry leaf in some reports), with minor alkaloids including isoboldine, reticuline, laurotetanine, and norisocorydine. Flavonoids including quercetin and kaempferol glycosides are present at approximately 1-3% dry weight collectively. Phenolic acids include gallic acid and protocatechuic acid (concentrations vary by harvest and preparation, roughly 2-5 mg/g dry leaf reported for total phenolics in some extracts). Essential oil constituents include ascaridole (a toxic monoterpene peroxide, ~15-30% of essential oil fraction), p-cymene, eucalyptol (1,8-cineole), and linalool. Tannins contribute to astringency. Bioavailability notes: Boldine exhibits moderate oral bioavailability in animal models with hepatic first-pass metabolism; ascaridole content raises safety concerns limiting internal use of essential oil preparations; aqueous infusions (traditional tea) reduce essential oil exposure compared to ethanolic extracts; flavonoid bioavailability is subject to gut microbiome metabolism as with most plant polyphenols. Human pharmacokinetic data for boldo constituents remains limited.
Reported Mechanism (Provisional)
Boldo's primary bioactive compound boldine acts as an antioxidant by scavenging free radicals and protecting cellular membranes from lipid peroxidation. The phenolic compounds including gallic acid and quercetin contribute to antioxidant activity through electron donation mechanisms. Essential oils containing eucalyptol and camphor provide antimicrobial effects by disrupting bacterial cell membranes.
Clinical Narrative (Provisional)
Current evidence for boldo is limited to in vitro laboratory studies demonstrating antioxidant activity from phenolic compounds. Antimicrobial effects have been shown in test-tube studies using essential oil extracts against various bacterial and fungal pathogens. No randomized controlled trials in humans have been conducted to validate traditional uses. The existing research consists primarily of preliminary laboratory investigations without clinical translation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.